ANRO
Alto Neuroscience·NYSE
--
--(--)
--
--(--)
ANRO fundamentals
Alto Neuroscience (ANRO) released its earnings on Aug 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.65 (YoY -8.33%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.65
-8.33%
Report date
Aug 13, 2025
Earnings Call
4:00 PM on Aug 13, 2025
Meeting link.EPS
Actual | -0.6 | -0.52 | -0.56 | -0.65 |
Forecast | -0.6567 | -0.6458 | -0.6086 | -0.5986 |
Surprise | +8.63% | +19.48% | +7.99% | -8.59% |
Revenue
Actual | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Alto Neuroscience’s earnings call?What factors drove the changes in Alto Neuroscience's revenue and profit?What is Alto Neuroscience's gross profit margin?What does Alto Neuroscience do and what are its main business segments?What is the revenue and EPS growth rate for Alto Neuroscience year over year?What is the market's earnings forecast for Alto Neuroscience next quarter?What guidance did Alto Neuroscience's management provide for the next earnings period?What is Alto Neuroscience's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
